Clinical Trial Update: A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial update for SHR-1826 in non-small cell lung cancer; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR-1826

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING